{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:32:01Z","timestamp":1792791121899,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018948","name":"Saudi Arabian Cultural Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018948","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiovascular Research Institute Maastricht","award":["HS-BAFTA fellowship"],"award-info":[{"award-number":["HS-BAFTA fellowship"]}],"id":[{"id":"https:\/\/ror.org\/032qqvq76","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Department of Health","award":["National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award"],"award-info":[{"award-number":["National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award"]}]},{"name":"NIHR MedTech Co-operative"},{"DOI":"10.13039\/501100023312","name":"Wellcome\/EPSRC Centre for Medical Engineering","doi-asserted-by":"crossref","award":["WT 203148\/Z\/16\/Z"],"award-info":[{"award-number":["WT 203148\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100023312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dark-blood late gadolinium enhancement (LGE) has been shown to improve the visualization and quantification of areas of ischemic scar compared to standard bright-blood LGE. Recently, the performance of various semi-automated quantification methods has been evaluated for the assessment of infarct size using both dark-blood LGE and conventional bright-blood LGE with histopathology as a reference standard. However, the impact of this sequence on different quantification strategies in vivo remains uncertain. In this study, various semi-automated scar quantification methods were evaluated for a range of different ischemic and non-ischemic pathologies encountered in clinical practice. A total of 62 patients referred for clinical cardiovascular magnetic resonance (CMR) were retrospectively included. All patients had a confirmed diagnosis of either ischemic heart disease (IHD; n\u2009=\u200921), dilated\/non-ischemic cardiomyopathy (NICM; n\u2009=\u200921), or hypertrophic cardiomyopathy (HCM; n\u2009=\u200920) and underwent CMR on a 1.5\u00a0T scanner including both bright- and dark-blood LGE using a standard PSIR sequence. Both methods used identical sequence settings as per clinical protocol, apart from the inversion time parameter, which was set differently. All short-axis LGE images with scar were manually segmented for epicardial and endocardial borders. The extent of LGE was then measured visually by manual signal thresholding, and semi-automatically by signal thresholding using the standard deviation (SD) and the full width at half maximum (FWHM) methods. For all quantification methods in the IHD group, except the 6 SD method, dark-blood LGE detected significantly more enhancement compared to bright-blood LGE (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05 for all methods). For both bright-blood and dark-blood LGE, the 6 SD method correlated best with manual thresholding (16.9% vs. 17.1% and 20.1% vs. 20.4%, respectively). For the NICM group, no significant differences between LGE methods were found. For bright-blood LGE, the 5 SD method agreed best with manual thresholding (9.3% vs. 11.0%), while for dark-blood LGE the 4 SD method agreed best (12.6% vs. 11.5%). Similarly, for the HCM group no significant differences between LGE methods were found. For bright-blood LGE, the 6 SD method agreed best with manual thresholding (10.9% vs. 12.2%), while for dark-blood LGE the 5 SD method agreed best (13.2% vs. 11.5%). Semi-automated LGE quantification using dark-blood LGE images is feasible in both patients with ischemic and non-ischemic scar patterns. Given the advantage in detecting scar in patients with ischemic heart disease and no disadvantage in patients with non-ischemic scar, dark-blood LGE can be readily and widely adopted into clinical practice without compromising on quantification.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-52058-8","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T02:02:01Z","timestamp":1709604121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Quantification of myocardial scar of different etiology using dark- and bright-blood late gadolinium enhancement cardiovascular magnetic resonance"],"prefix":"10.1038","volume":"14","author":[{"given":"Lamis","family":"Jada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Holtackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig M. J. M.","family":"Nies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Van De Heyning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene M.","family":"Botnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim E.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik F.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Chiribiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"9249","key":"52058_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0140-6736(00)03567-4","volume":"357","author":"E Wu","year":"2001","unstructured":"Wu, E. et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357(9249), 21\u201328 (2001).","journal-title":"Lancet"},{"issue":"6","key":"52058_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10554-008-9300-x","volume":"24","author":"S Bohl","year":"2008","unstructured":"Bohl, S. et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int. J. Cardiovasc. Imaging. 24(6), 597\u2013607 (2008).","journal-title":"Int. J. Cardiovasc. Imaging."},{"issue":"20","key":"52058_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","volume":"343","author":"RJ Kim","year":"2000","unstructured":"Kim, R. J. et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med. 343(20), 1445\u20131453 (2000).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"52058_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1148\/radiology.218.1.r01ja50215","volume":"218","author":"OP Simonetti","year":"2001","unstructured":"Simonetti, O. P. et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 218(1), 215\u2013223 (2001).","journal-title":"Radiology."},{"issue":"1","key":"52058_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12968-021-00777-6","volume":"23","author":"RJ Holtackers","year":"2021","unstructured":"Holtackers, R. J. et al. Dark-blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of subendocardial scar: A review of current techniques. J. Cardiovasc. Magn. Reson. 23(1), 96 (2021).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"12","key":"52058_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.jcmg.2017.09.021","volume":"11","author":"HW Kim","year":"2018","unstructured":"Kim, H. W. et al. Dark-blood delayed enhancement cardiac magnetic resonance of myocardial infarction. JACC Cardiovasc. Imaging. 11(12), 1758\u20131769 (2018).","journal-title":"JACC Cardiovasc. Imaging."},{"issue":"1","key":"52058_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12968-016-0297-3","volume":"18","author":"P Kellman","year":"2016","unstructured":"Kellman, P. et al. Dark blood late enhancement imaging. J. Cardiovasc. Magn. Reson. 18(1), 77 (2016).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"5","key":"52058_CR8","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/jmri.25498","volume":"45","author":"G Muscogiuri","year":"2017","unstructured":"Muscogiuri, G. et al. T(Rho) and magnetization transfer and INvErsion recovery (TRAMINER)-prepared imaging: A novel contrast-enhanced flow-independent dark-blood technique for the evaluation of myocardial late gadolinium enhancement in patients with myocardial infarction. J. Magn. Reson. Imaging. 45(5), 1429\u20131437 (2017).","journal-title":"J. Magn. Reson. Imaging."},{"issue":"1","key":"52058_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12968-017-0372-4","volume":"19","author":"RJ Holtackers","year":"2017","unstructured":"Holtackers, R. J. et al. Dark-blood late gadolinium enhancement without additional magnetization preparation. J. Cardiovasc. Magn. Reson. 19(1), 64 (2017).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"1","key":"52058_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/jmri.26613","volume":"50","author":"JRJ Foley","year":"2019","unstructured":"Foley, J. R. J. et al. Clinical evaluation of two dark blood methods of late gadolinium quantification of ischemic scar. J. Magn. Reson. Imaging. 50(1), 146\u2013152 (2019).","journal-title":"J. Magn. Reson. Imaging."},{"issue":"1","key":"52058_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12968-019-0556-1","volume":"21","author":"RJ Holtackers","year":"2019","unstructured":"Holtackers, R. J. et al. Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation. J. Cardiovasc. Magn. Reson. 21(1), 44 (2019).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"1","key":"52058_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jmri.27805","volume":"55","author":"RJ Holtackers","year":"2022","unstructured":"Holtackers, R. J. et al. Histopathological validation of dark-blood late gadolinium enhancement MRI without additional magnetization preparation. J. Magn. Reson. Imaging. 55(1), 190\u2013197 (2022).","journal-title":"J. Magn. Reson. Imaging."},{"issue":"1","key":"52058_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger, J. et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J. Cardiovasc. Magn. Reson. 22(1), 19 (2020).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"6","key":"52058_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan, R. H. et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 130(6), 484\u2013495 (2014).","journal-title":"Circulation."},{"issue":"1","key":"52058_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","volume":"22","author":"CM Kramer","year":"2020","unstructured":"Kramer, C. M. et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J. Cardiovasc. Magn. Reson. 22(1), 17 (2020).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"3","key":"52058_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ehjci\/jeac107","volume":"24","author":"HMJM Nies","year":"2023","unstructured":"Nies, H. M. J. M. et al. Histopathological validation of semi-automated myocardial scar quantification techniques for dark-blood late gadolinium enhancement magnetic resonance imaging. Eur. Heart J. Cardiovasc. Imaging. 24(3), 364\u2013372 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Imaging."},{"issue":"2","key":"52058_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","volume":"4","author":"AS Flett","year":"2011","unstructured":"Flett, A. S. et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc. Imaging. 4(2), 150\u2013156 (2011).","journal-title":"JACC Cardiovasc. Imaging."},{"issue":"19","key":"52058_CR18","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","volume":"100","author":"RJ Kim","year":"1999","unstructured":"Kim, R. J. et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 100(19), 1992\u20132002 (1999).","journal-title":"Circulation."},{"issue":"9","key":"52058_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/hc3401.095113","volume":"104","author":"BL Gerber","year":"2001","unstructured":"Gerber, B. L. et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation. 104(9), 998\u20131004 (2001).","journal-title":"Circulation."},{"issue":"23","key":"52058_CR20","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1161\/hc4801.100351","volume":"104","author":"JN Oshinski","year":"2001","unstructured":"Oshinski, J. N. et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation. 104(23), 2838\u20132842 (2001).","journal-title":"Circulation."},{"issue":"6","key":"52058_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0735-1097(00)00958-X","volume":"36","author":"DS Fieno","year":"2000","unstructured":"Fieno, D. S. et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J. Am. Coll. Cardiol. 36(6), 1985\u20131991 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"52058_CR22","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1161\/01.CIR.102.14.1678","volume":"102","author":"HB Hillenbrand","year":"2000","unstructured":"Hillenbrand, H. B. et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation. 102(14), 1678\u20131683 (2000).","journal-title":"Circulation."},{"issue":"2","key":"52058_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1081\/JCMR-200053623","volume":"7","author":"O Bondarenko","year":"2005","unstructured":"Bondarenko, O. et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J. Cardiovasc. Magn. Reson. 7(2), 481\u2013485 (2005).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"2","key":"52058_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/jmri.23814","volume":"37","author":"E Vermes","year":"2013","unstructured":"Vermes, E. et al. Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease. J. Magn. Reson. Imaging. 37(2), 382\u2013390 (2013).","journal-title":"J. Magn. Reson. Imaging."},{"issue":"12","key":"52058_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.acra.2011.08.002","volume":"18","author":"K Gruszczynska","year":"2011","unstructured":"Gruszczynska, K. et al. Different algorithms for quantitative analysis of myocardial infarction with DE MRI: Comparison with autopsy specimen measurements. Acad. Radiol. 18(12), 1529\u20131536 (2011).","journal-title":"Acad. Radiol."},{"issue":"1","key":"52058_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12968-019-0561-4","volume":"21","author":"P Freitas","year":"2019","unstructured":"Freitas, P. et al. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death. J. Cardiovasc. Magn. Reson. 21(1), 50 (2019).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"9","key":"52058_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati, A. et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 309(9), 896\u2013908 (2013).","journal-title":"JAMA."},{"issue":"1","key":"52058_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12968-016-0300-z","volume":"18","author":"Y Mikami","year":"2016","unstructured":"Mikami, Y. et al. Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: Validation for the prediction of future cardiovascular events. J. Cardiovasc. Magn. Reson. 18(1), 82 (2016).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"3","key":"52058_CR29","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.ejrad.2009.05.035","volume":"74","author":"M Spiewak","year":"2010","unstructured":"Spiewak, M. et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur. J. Radiol. 74(3), e149-153 (2010).","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"52058_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1148\/radiol.10090526","volume":"258","author":"CJ Harrigan","year":"2011","unstructured":"Harrigan, C. J. et al. Hypertrophic cardiomyopathy: Quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258(1), 128\u2013133 (2011).","journal-title":"Radiology"},{"issue":"Supplement_2","key":"52058_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ehjci\/jez112.003","volume":"20","author":"T Kotecha","year":"2019","unstructured":"Kotecha, T. et al. Quantification of myocardial infarct size and microvascular obstruction using dark-blood late gadolinium enhancement. Eur. Heart J. Cardiovasc. Imaging. 20(Supplement_2), 48 (2019).","journal-title":"Eur. Heart J. Cardiovasc. Imaging."},{"issue":"1","key":"52058_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Otsu","year":"1979","unstructured":"Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Man. Cyberb. 9(1), 62\u201366 (1979).","journal-title":"IEEE Trans. Man. Cyberb."},{"issue":"9","key":"52058_CR33","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3390\/diagnostics13091634","volume":"13","author":"JM Brendel","year":"2023","unstructured":"Brendel, J. M. et al. Dark-blood late gadolinium enhancement MRI is noninferior to bright-blood LGE in non-ischemic cardiomyopathies. Diagnostics (Basel). 13(9), 1634 (2023).","journal-title":"Diagnostics (Basel)."},{"issue":"5","key":"52058_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/RLI.0000000000000747","volume":"56","author":"RJ Holtackers","year":"2021","unstructured":"Holtackers, R. J. et al. Steadily increasing inversion time improves blood suppression for free-breathing 3D late gadolinium enhancement MRI with optimized dark-blood contrast. Invest Radiol. 56(5), 335\u2013340 (2021).","journal-title":"Invest Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-52058-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-52058-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-52058-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T02:05:07Z","timestamp":1709604307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-52058-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52058"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-52058-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5395"}}